opentrade on
↗
event5 outcomes
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
vol cum
$21.4k
vol 24h
$1.9k
outcomes
5
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
92¢
· 0.0pp
24h change
vol cum
$1.1k
vol 24h
$0
spread
0.08
ends
Jan 8, 2028
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdataWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
before November80¢▲ 24.0ppbefore 202777¢▼ 1.0ppbefore April 202783¢· 0.0pp
+3 others
$771 24h · 6 markets
FDA approves Retatrutide this year?
yes3¢▼ 1.8pp
$0 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢
M0 24h · 1 market
Will the FDA approve any psychedelic substance for medical use this year?
yes26¢▼ 3.0pp
$421 24h · 1 market
Eli Lilly licenses Peptron’s SmartDepot by October 7?
yes11¢▼ 2.0pp
$70 24h · 1 market
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢
M0 24h · 1 market